Citigroup Rates BSX as ‘Outperform,’ Analysts Respond

Recent analyst forecasts indicate a favorable outlook for $BSX. Citigroup has assigned an ‘Outperform’ rating, reflecting confidence in the stock’s performance potential.

Latest Analyst Ratings for $BSX

In recent months, Wall Street analysts have actively covered $BSX. A total of 10 firms have provided buy ratings, and only 1 firm has issued a sell rating, indicating strong positive sentiment.

Here are some notable analyst ratings:

• Citigroup: “Outperform” as of 04/18/2025
• Needham: “Buy” as of 04/16/2025
• Cowen & Co.: “Buy” as of 02/03/2025
• Piper Sandler: “Overweight” as of 02/03/2025
• Deutsche Bank: “Buy” as of 01/10/2025
• Bernstein: “Outperform” as of 01/08/2025
• Evercore ISI: “Outperform” as of 01/02/2025

For a comprehensive overview of analyst ratings and price targets, please visit Quiver Quantitative’s $BSX forecast page.

Current Price Targets for $BSX

Several analysts have established price targets for $BSX in the past few months. Over the last six months, 6 analysts have proposed price targets with a median target of $99.00.

Recent price targets include:

• Matt O’Brien (Piper Sandler): Target price of $115.00 on 02/03/2025
• Vijay Kumar (Evercore ISI): Target price of $100.00 on 01/02/2025
• Marie Thibault (BTIG): Target price of $101.00 on 12/30/2024
• Shagun Singh (RBC Capital): Target price of $98.00 on 10/24/2024
• Kristen Stewart (C.L. King): Target price of $90.00 on 10/24/2024
• William Plovanic (Canaccord Genuity): Target price of $98.00 on 10/21/2024

Congressional Stock Trading Activity for $BSX

In the past six months, members of Congress have engaged in trading $BSX, with a total of 4 transactions recorded—2 purchases and 2 sales.

To understand the specifics of these trades, you can refer to Quiver Quantitative’s congressional trading dashboard.

Insider Trading Activity for $BSX

Insiders at $BSX participated in 31 trades over the last six months, with only 1 purchase and 30 sales.

Here’s a summary of insider trading activities:

• MICHAEL F MAHONEY (Chairman, President & CEO): 0 purchases, 3 sales; 327,220 shares sold for approximately $30,239,922.
• DANIEL J. BRENNAN (EVP and CFO): 0 purchases, 4 sales; 99,950 shares sold for approximately $10,504,430.
• JOHN BRADLEY SORENSON (EVP, Global Operations): 0 purchases, 6 sales; 50,658 shares sold for approximately $4,789,604.
• ARTHUR C BUTCHER (EVP & Group President, MedSurg & APAC): 0 purchases, 3 sales; 31,323 shares sold for approximately $3,013,171.
• JEFFREY B. MIRVISS (EVP & President, Peripheral Intervent): 0 purchases, 4 sales; 21,895 shares sold for approximately $2,294,072.
• EDWARD J LUDWIG: 0 purchases, 2 sales; 16,877 shares sold for approximately $1,712,717.
• ELLEN M ZANE: Sold 13,586 shares for approximately $1,416,133.
• WENDY CARRUTHERS (EVP, Human Resources): 0 purchases, 2 sales; 13,966 shares sold for approximately $1,222,793.
• EMILY WOODWORTH (SVP, Global Controller and CAO): 0 purchases, 2 sales; 11,223 shares sold for approximately $1,120,977.
• VANCE R BROWN (SVP, GC and Corporate Secretary): 0 purchases, 2 sales; 9,652 shares sold for approximately $991,694.
• JOSEPH MICHAEL FITZGERALD (EVP & Group President, Cardiology): 1 purchase; 50 shares bought for approximately $4,514 and 1 sale; 20 shares sold for approximately $1,799.

For detailed insights into insider transactions, visit Quiver Quantitative’s insider trading dashboard.

Recent Hedge Fund Activity Around $BSX

In the recent quarter, 748 institutional investors increased their positions in $BSX shares, while 582 reduced their holdings.

Here are some significant trades from the latest quarter:

• BLACKROCK, INC. increased holdings by 10,325,678 shares (+8.0%) in Q4 2024, valued at approximately $922,289,558.
• CAPITAL WORLD INVESTORS added 6,216,199 shares (+28.7%) in Q4 2024, valued at approximately $555,230,894.
• MASSACHUSETTS FINANCIAL SERVICES CO/MA removed 6,007,738 shares (-23.4%) in Q4 2024, valued at approximately $536,611,158.
• CITADEL ADVISORS LLC decreased holdings by 4,861,651 shares (-49.6%) in Q4 2024, valued at approximately $434,242,667.
• WELLINGTON MANAGEMENT GROUP LLP added 3,344,571 shares (+10.2%) in Q4 2024, valued at approximately $298,737,081.
• FMR LLC removed 2,754,011 shares (-2.0%) in Q4 2024, valued at approximately $245,988,262.
• LEGAL & GENERAL GROUP PLC decreased its position by 2,743,301 shares (-20.3%) in Q4 2024, valued at approximately $245,031,645.

For insights into hedge fund holdings, check out Quiver Quantitative’s institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative’s disclaimers for further details.

This article was originally published on Quiver News. For the complete story, read on.

The views and opinions expressed herein are solely those of the author and do not necessarily reflect those of Nasdaq, Inc.